Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy.

导出 OA

翻译打印收藏纠错

作者： Serena,Di Cosimo ^[1] ; Valentina,Appierto ^[1] ; Marco,Silvestri ^[1] ; Giancarlo,Pruneri ^[2] ; Andrea,Vingiani ^[2] ; Federica,Perrone ^[1] ; Adele,Busico ^[1] ; Secondo,Folli ^[1] ; Gianfranco,Scaperrotta ^[1] ; Filippo Guglielmo,de Braud ^[2] ; Giulia Valeria,Bianchi ^[1] ; Stefano,Cavalieri ^[1] ; Maria Grazia,Daidone ^[1] ; Matteo,Dugo ^[1]

作者单位： Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Giovanni Antonio Amadeo 42, 20133 Milano, Italy. ^[1] Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Giovanni Antonio Amadeo 42, 20133 Milano, Italy.;Oncology and Hemato-Oncology Department, University of Milan, Via Festa del Perdono 7, 20122 Milano, Italy. ^[2]

关键词 biopsies cancer therapy heterogeneity neo-adjuvant chemotherapy somatic mutations targeted-gene sequencing triple negative breast cancer

DOI 10.3390/cancers11111753

PMID 31717320

发布时间 2024-07-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交